Tomorrow is my second cataract surgery, and I’m actually looking forward to it. Dr. Callahan is professional, thorough, answers every question, and her kind, caring staff makes all the difference.
Pam Knisely
Proliferative Diabetic Retinopathy: What You Need to Know
Types and Severity of PDR
Not all cases of PDR carry the same level of risk, and your eye doctor will evaluate the specific features of your disease to guide treatment decisions. Understanding the different presentations of PDR can help you appreciate why timing and urgency vary from case to case.
In early PDR, new blood vessels have just begun to develop and complications such as vitreous hemorrhage or retinal detachment have not yet occurred. Your eye doctor may detect small tufts of new vessels on the retinal surface or near the optic disc during a dilated exam or on retinal imaging. At this stage, the disease is still very manageable, and early intervention can substantially reduce the risk of the serious complications associated with more advanced PDR. Early recognition and prompt treatment offer the best opportunity to keep PDR under control.
High-risk PDR is a more advanced form that carries a particularly elevated threat of severe vision loss. It is defined by specific features that research has identified as being associated with the worst outcomes when left untreated.
- Neovascularization of the disc covering approximately one-third or more of the disc area
- Any NVD combined with vitreous hemorrhage or preretinal hemorrhage
- Neovascularization elsewhere covering at least half the disc area combined with vitreous hemorrhage or preretinal hemorrhage
When these features are present, the risk of severe vision loss without treatment is substantial. High-risk PDR is considered an urgent indication for treatment, and your eye doctor will typically recommend starting therapy as soon as possible.
Vitreous hemorrhage occurs when the fragile new blood vessels of PDR rupture and bleed into the vitreous cavity. The amount of bleeding can range from a small amount that causes new floaters to a dense hemorrhage that clouds vision dramatically. A mild vitreous hemorrhage may clear partially on its own over weeks to months as the blood is gradually absorbed, though vision may remain blurry during this time. A dense hemorrhage that does not clear may require a surgical procedure called vitrectomy, in which the blood-filled vitreous gel is removed and replaced with a clear solution. Even after a hemorrhage resolves, the underlying PDR must still be treated to prevent it from happening again.
As fibrous tissue associated with neovascularization contracts, it can pull the retina away from its underlying attachment, a condition called tractional retinal detachment (TRD). A TRD that involves only the peripheral retina may not cause immediate symptoms but requires close monitoring. If the traction extends toward or involves the macula, it can cause severe distortion or loss of central vision. A macula-threatening tractional retinal detachment is considered a surgical emergency and typically requires vitrectomy surgery to relieve the traction and reattach the retina. Visual outcome depends significantly on how quickly the detachment is addressed and whether the macula has already been affected.
How PDR Is Diagnosed and Monitored
Detecting and tracking PDR requires a combination of hands-on examination and advanced imaging technology. Our eye doctors use several complementary tools to build a complete picture of your retinal health over time.
The dilated eye exam remains the foundation of PDR diagnosis and monitoring. Your eye doctor places drops in your eyes to widen your pupils, then examines the retina using specialized lenses and instruments. This direct examination allows detection of neovascularization, hemorrhage, fibrous tissue, and retinal detachment. Both eyes are evaluated at each visit, as PDR can affect one or both eyes and the severity may differ between them. No imaging tool fully replaces what a thorough dilated exam can reveal.
Imaging technology provides documentation and detail that complements the clinical exam. Fundus photography captures high-resolution color images of the retinal surface, creating a visual record that can be compared at future visits to track changes over time. Optical coherence tomography, or OCT, creates detailed cross-sectional images of the retinal layers and can detect macular edema (swelling in the center of the retina), tractional changes, or early signs of retinal detachment. Widefield imaging allows a broader view of the peripheral retina, which is important because neovascularization and ischemia can extend far beyond the central area.
Fluorescein angiography (FA) is a specialized test in which a fluorescent dye is injected into a vein in your arm and photographed as it passes through the retinal blood vessels. This test reveals the full extent of neovascularization, areas of active leakage from abnormal vessels, and the distribution of nonperfusion, meaning areas where capillaries have closed and blood flow has stopped entirely. FA helps your eye doctor assess how much of the retina is ischemic, which directly influences treatment planning. It can also detect subtle new vessel growth that may not be visible on standard examination or photography.
OCT angiography (OCTA) is a newer imaging technique that maps retinal blood flow without requiring injected dye. It uses the movement of red blood cells to create detailed images of the capillary networks within different retinal layers. OCTA is useful for tracking areas of capillary dropout and monitoring how neovascularization responds to treatment over time. While it does not replace fluorescein angiography for comprehensive assessment, it provides a noninvasive way to monitor blood flow changes between visits and helps your eye doctor detect subtle shifts in vascular health.
Treatment Options for Proliferative Diabetic Retinopathy
There are several effective treatments for PDR, and your eye doctor will select the approach that best fits your individual situation. In many cases, treatments are used in combination to achieve the best possible outcome.
Anti-VEGF injections are one of the primary treatments for PDR. These medications are injected directly into the vitreous cavity of the eye and work by blocking vascular endothelial growth factor, the molecule that drives the growth of abnormal blood vessels. By neutralizing VEGF, the injections can cause existing neovascularization to shrink, reduce the risk of vitreous hemorrhage, and help stabilize the retina. The injections are performed in the office using numbing drops to minimize discomfort. Treatment typically involves a series of injections over time, with frequency adjusted based on how your retina responds. Anti-VEGF therapy has become a central component of PDR management and is highly effective at controlling abnormal vessel growth in many patients.
Panretinal photocoagulation, known as PRP, is a laser treatment with a long track record in PDR management. During PRP, your eye doctor applies hundreds to thousands of small laser burns to the peripheral areas of the retina, away from the macula. By treating these peripheral areas, PRP reduces the total oxygen demand of the retina. With less ischemic tissue releasing VEGF, the stimulus for neovascularization decreases and the abnormal vessels may regress. PRP is typically completed over one to three sessions and provides durable, long-lasting effects once finished. Potential side effects include some reduction in peripheral vision, decreased night vision, and mild changes in color perception. Your eye doctor will explain why the benefits of treatment typically outweigh these effects when PDR is present.
Vitrectomy is a surgical procedure that may be necessary when PDR has caused complications that cannot be managed with injections or laser alone. During vitrectomy, a retinal surgeon removes the vitreous gel from inside the eye, along with any blood from vitreous hemorrhage and any fibrous tissue pulling on the retina. If a tractional retinal detachment is present, the surgeon works to relieve the traction and reattach the retina. The vitreous is replaced with a clear solution or a gas bubble that supports healing. Recovery involves following specific positioning and activity instructions from your surgical team. While vitrectomy is a more involved procedure, it can be vision-saving in cases of dense vitreous hemorrhage or macula-threatening retinal detachment.
In many cases, your eye doctor will use a combination of approaches to manage PDR effectively. Anti-VEGF injections may be given first to reduce neovascularization, followed by PRP laser to provide more durable long-term control. If a vitreous hemorrhage occurs, anti-VEGF injections may be given before vitrectomy to reduce bleeding during the operation. The specific combination of treatments depends on the severity of your PDR, whether complications are present, and how your retina responds to initial therapy. Your eye doctor will develop and continually adjust an individualized plan at each follow-up visit.
Living With PDR: What You Can Control
Medical treatment is essential for managing PDR, but the choices you make every day also play a meaningful role in protecting your vision. Several factors within your control can significantly influence how your disease progresses.
Even after a PDR diagnosis, blood sugar management remains critically important. Keeping your hemoglobin A1c within the target range recommended by your diabetes care team reduces ongoing damage to retinal blood vessels and supports the effectiveness of your eye treatments. Poor blood sugar control can accelerate the progression of PDR, increase the frequency of vitreous hemorrhages, and make treatment less effective. Working closely with your diabetes care team to optimize medications, meal planning, and physical activity provides the best foundation for your eye care to succeed.
High blood pressure adds additional stress to the already compromised blood vessels in your retina and increases the risk of bleeding and other complications in PDR. Managing blood pressure within recommended targets helps reduce this added risk. Cholesterol and triglyceride management also contribute to overall vascular health. If you smoke, quitting is one of the most impactful steps you can take, as smoking constricts blood vessels, worsens ischemia, and accelerates retinal damage. A comprehensive approach to cardiovascular health supports not only your retinal health but your overall wellbeing.
PDR requires ongoing, active management. Missing or delaying appointments can allow the disease to progress between visits, potentially leading to complications that could have been prevented with earlier attention. Your eye doctor will set a monitoring schedule based on the severity of your PDR and your response to treatment, which may mean visits every one to three months, sometimes more frequently during active treatment phases. Anti-VEGF injections need to be repeated on a regular schedule to maintain their effect, and PRP may require additional sessions. Consistent follow-through is one of the most important things you can do to protect your vision.
When you have PDR, knowing the warning signs that require immediate attention is essential. Contact your eye doctor right away if you notice any of the following symptoms.
- A sudden increase in floaters, particularly dark spots, strings, or cobweb-like shapes
- A sudden, significant darkening or blurring of your vision
- Flashes of light in your peripheral vision
- A shadow or curtain effect across part of your visual field
- A rapid decline in your ability to read or see faces clearly
These symptoms may indicate vitreous hemorrhage or retinal detachment, both of which benefit greatly from prompt evaluation and treatment. Do not wait for your next scheduled appointment if these symptoms appear, as rapid response can make a meaningful difference in the outcome.
Long-Term Outlook and What to Expect
PDR is a serious condition, but with consistent treatment and good overall health management, many people preserve functional vision for years. Understanding the realistic goals of treatment helps you stay engaged and motivated in your care.
Treatment can cause the abnormal blood vessels of PDR to regress and reduce the activity of the disease, but PDR cannot be fully reversed to a pre-disease state. The structural damage to the retinal capillary network that has accumulated over years of diabetes remains, and areas of the retina that have been ischemic do not recover their lost blood supply. The realistic goal of treatment is to control the disease, prevent further damage, and preserve the vision you currently have. With consistent treatment and diligent health management, many people with PDR maintain useful functional vision for years after diagnosis.
Untreated PDR carries a significant risk of severe vision loss. The fragile neovascularization continues to grow, the risk of vitreous hemorrhage increases, and fibrous tissue can progressively contract and cause tractional retinal detachment. High-risk PDR that is not treated can lead to profound vision impairment relatively quickly. The availability of effective treatments makes it critically important to follow through with the care your eye doctor recommends. The difference in visual outcomes between treated and untreated PDR is substantial, and prompt, consistent treatment gives you the best chance of preserving meaningful vision.
If you have PDR in one eye, your other eye is also at significant risk. Diabetic retinopathy is driven by the systemic effects of diabetes on blood vessels throughout the body, meaning both eyes face the same underlying risk factors. Your eye doctor will monitor both eyes carefully at every visit, even if only one has progressed to PDR. The severity may differ between the two eyes, and the management plan for each eye may be different. Protecting your vision fully requires attention to both eyes at every appointment.
Frequently Asked Questions
Below are answers to some of the questions our patients ask most often about proliferative diabetic retinopathy. These answers are intended to offer practical guidance that goes beyond what is covered in the sections above.
A PDR diagnosis does not mean blindness is inevitable. While PDR is the most serious stage of diabetic retinopathy, the availability of anti-VEGF injections, laser treatment, and surgery has significantly changed outcomes for patients. Many people with PDR retain functional, useful vision for years with appropriate treatment. The most important factors in your outcome are how consistently you attend follow-up appointments, how well your diabetes and blood pressure are managed, and how quickly you seek care when new symptoms appear. Early and consistent treatment dramatically changes the prognosis compared to no treatment.
Your eye doctor determines whether your PDR falls into the high-risk category based on what is seen during your dilated exam and on retinal imaging. High-risk PDR involves specific features related to the size and location of new vessel growth and whether bleeding has already occurred. If your PDR is classified as high-risk, your doctor will communicate this clearly and will typically recommend beginning treatment without delay. It is appropriate to ask your doctor at any appointment where your disease currently stands and whether the classification has changed since your last visit.
Many people with PDR continue to drive and work depending on whether their central vision remains intact and no active vitreous hemorrhage is obscuring their sight. If a significant hemorrhage has occurred or if you are recovering from vitrectomy surgery, your driving ability and daily activities will need to be evaluated by your eye doctor based on your actual visual function at that time. It is important not to assume your vision is safe for driving if you have noticed any sudden changes. Your eye doctor can provide specific guidance about activity restrictions based on your current status.
The frequency of anti-VEGF injections varies from patient to patient and changes over time based on how the retina responds. In the early phases of treatment, injections are often given monthly or every few weeks. As the disease is brought under control, the interval between injections may be extended. Some patients require ongoing injections to maintain the benefit, while others may be able to transition to less frequent monitoring after a period of stability. Your eye doctor will adjust the treatment schedule at each visit based on your imaging results and clinical findings. It is important not to skip injections without discussing it with your doctor first, as the disease can become active again between visits.
Both PRP laser and anti-VEGF injections are effective treatments for PDR, but they work differently and are used in different ways. Anti-VEGF injections directly block the growth factor that drives abnormal vessel formation and typically need to be repeated regularly to maintain their effect. PRP laser works by reducing the retina's oxygen demand, which lowers the stimulus for new vessel growth, and its effects are more durable once the full treatment is complete. The choice between them, or whether to use both, depends on your specific disease features, whether complications have already occurred, and your overall treatment response. Your eye doctor will explain the rationale for whichever approach or combination is recommended for your situation.
PDR management often involves collaboration between your comprehensive eye doctor and a retinal specialist. Routine monitoring, imaging, and anti-VEGF injections may be managed by an ophthalmologist experienced in medical retina care, while complex surgical cases involving vitreous hemorrhage or retinal detachment typically require a fellowship-trained vitreoretinal surgeon. If your eye doctor determines that your case requires surgical intervention or specialized expertise, a referral will be made. The important thing is to stay in care with an eye doctor who can properly evaluate your retina and coordinate the appropriate level of treatment for your specific situation.
Schedule Your Evaluation at NewView Eye Center
If you have been diagnosed with proliferative diabetic retinopathy, or if you are concerned about changes in your vision related to diabetes, our team at NewView Eye Center is here to help. We are proud to serve patients across Northern Virginia with personalized, expert eye care guided by a genuine commitment to preserving your vision. We encourage you to schedule a comprehensive evaluation so we can assess your retinal health, discuss your treatment options, and build a plan designed around your needs.
What our Patients Says
Explore More
Find more information about our doctors, services, and technology that keep your eyes healthy and your vision at its best.